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Abstract: Early recognition of ventricular tachycardias (VTs) with epicardial circuits is crucial. Surface electrocardiogram (ECG) suggesting 
an epicardial origin could guide ablation procedures and increase success rates. A 35-year-old female patient with VT treated by combined 
epicardial and endocardial ablation approach is presented in this report, and the role of surface electrocardiogram and timing of epicardial 
access is discussed.
Keywords: ventricular tachycardia, ablation, epicardial, endocardial, surface electrocardiogram
Introduction
Radio frequency (RF) catheter ablation of ventricular 
tachycardia (VT) ablation is a challenging procedure with 
limited success rates. Presence of epicardial circuits is an 
important cause of these failed endocardial ablations [1]. 
According to data of a multicenter study, 17% of VT abla-
tions involved epicardial mapping [2]. Therefore, char-
acteristics of VT and underlying heart disease should be 
considered before deciding the ablation strategy. Twelve-
lead surface electrocardiogram (ECG) during arrhythmia 
could be helpful to identify the origin of VT. In this re-
port, we discuss the role of surface ECG over a case of VT 
treated by combined epicardial and endocardial approach.
Case Report
A 53-year-old female with nonischemic cardiomyopathy 
and left ventricular (LV) systolic dysfunction had under-
gone cardiac resynchronization therapy with implant-
able cardioverter deﬁ brillator (CRT-D). Three months 
after the implantation, she experienced palpitations. 
ECG during symptoms revealed wide QRS tachycardia 
with a cycle length of 480 ms. CRT-D recordings re-
vealed 84 VT episodes. Although most of them were 
nonsustained, 24 of them were terminated by antitachy-
cardia pacing (ATP). Because of frequent VT episodes 
and failure of antiarrhythmic therapy, she underwent 
electrophysiological study.
Sustained VT was induced easily by programmed 
ventricular stimulation. Morphology and cycle length of 
arrhythmia were same as clinical VT (Fig. 1). Right bun-
dle branch block (RBBB)-like conﬁ guration, wide QRS 
duration (337 ms), and pseudo-delta wave (149  ms) 
were suggesting epicardial origin. Therefore, we decided 
to start ablation procedure by epicardial mapping. After 
epicardial access via subxiphoid approach, hemodynami-
cally stable sustained clinical VT was induced. Electro-
anatomical mapping system (CARTO™, Biosense Web-
ster Inc., Diamond Bar, CA, USA) with a 7.5 French, 
3.5-mm-tip, open irrigated ablation catheter (Navistar 
ThermoCool™, Biosense Webster Inc.) was used for ac-
tivation mapping. Earliest activity was recorded at basal 
lateral LV. At this location, classic entrainment with con-
cealed fusion and best post-pacing interval (480 ms) was 
demonstrated (Fig.  2). High-output pacing and coro-
nary angiography were performed to conﬁ rm safe abla-
tion site. During ablation (40 W, 22 mL/min external 
irrigation ﬂ ow), morphology of the VT changed. QRS 
duration became narrower (190 ms), and pseudo-delta 
waves disappeared (Fig. 3). These ﬁ ndings were suggest-
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ing endocardial origin, and no early activation point was 
found during epicardial mapping of second VT (VT2).
Therefore, we decided to perform endocardial map-
ping. LV was accessed by retrograde trans-aortic ap-
proach. Endocardial activation mapping located earliest 
activity at basal lateral wall of LV, adjacent to successful 
ablation site of epicardial VT (Fig. 4). RF applications at 
this site terminated VT2. Thereafter, programmed ven-
tricular stimulation up to three extra stimuli failed to in-
duce any tachyarrhythmia. During more than 3 months 
of follow-up, patient had no symptoms and monthly 
ICD interrogations have not recorded any ventricular 
arrhythmic events.
Discussion
Early recognition of epicardial origin is crucial to avoid 
prolonged and unsuccessful endocardial ablation. 
Achieving an epicardial access before systemic antico-
Fig. 1. Twelve-lead surface ECG of ﬁ rst VT (epicardial). CL: cycle length; PdW: pseudo-delta 
wave: interval measured from the earliest ventricular activation to the onset of the earliest 
fast deﬂ ection in any precordial leads; MDI: interval measured from the earliest ventricular 
activation to the largest amplitude deﬂ ection in each precordial leads (taking the lead with 
shortest time)/QRS duration
Fig. 2. Cardiac tracings presenting classic entertainment with concealed fusion and best post-pacing 
interval. Map: mapping catheter; Rva: right ventricular catheter
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agulation is also safer. Epicardial approach could be an 
option for patients who have intra-ventricular thrombi 
or aortic prosthetic valve, especially epicardial VT is sus-
pected.
Unfortunately, it is hard to deﬁ ne a certain ECG cri-
teria for epicardial VT. Diff erent cutoff  values and mor-
phology criteria were published according to patient 
groups with diff erent heart diseases and normal hearts 
[3–6]. Furthermore, some of these studies only fo-
cused on locations where most of VTs originate. There-
fore, ECG criteria suitable for underlying heart disease 
should be used. Vallès et al. suggested a 4-step algorithm 
for identifying endo/epicardial origin in patients with 
nonischemic cardiomyopathy (sensitivity 96%, speci-
ﬁ city 93%) [6]. According to this algorithm, presence 
of q  waves in inferior leads excludes epicardial origin 
(step 1). Pseudo-delta wave ≥75 ms (step 2), maximum 
deﬂ ection index (MDI) ≥ 0.59 (step 3), and presence 
of q waves in lead I (step 4) were suggesting epicardial 
origin. First 3 steps had high speciﬁ city, and the last step 
was the most accurate. During epicardial VT, no q wave 
was observed neither in inferior leads nor in lead I. Pseu-
do-delta wave duration was 149 ms, and MDI was 0.70. 
Although successful ablation sites of both VTs were ad-
jacent to each other, QRS conﬁ gurations and intervals 
were diff erent. There were q waves in inferior leads of 
Fig. 3. Twelve-lead surface ECG of second VT (endocardial). Abbreviations are same as in the Fig. 1
Fig. 4. Epicardial and endocardial activation maps of VTs and successful ablation sites (red dots) 
adjacent to each other
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endocardial VT. Pseudo-delta waves disappeared, and 
MDI was 0.63. Diffi  culty to create transmural lesion on 
LV might be responsible from this morphological shift-
ing. Therefore, combined epicardial and endocardial ap-
proach seems feasible for patients with suspected epicar-
dial VTs. Not only ECG ﬁ ndings but history of patient 
is helpful as well. Failure of endocardial ablation could 
reﬂ ect an epicardial origin [7]. Prevalence of epicardial 
VT is higher in patients with chagas disease, nonischemic 
cardiomyopathy, and arrhythmogenic right ventricular 
cardiomyopathy. Magnetic resonance imaging may also 
help identifying an epicardial substrate [8].
In conclusion, surface ECG suggesting an epicardial 
origin could guide ablation procedures and increase suc-
cess rates. However, it should be considered that mor-
phology and interval are variable depending on substrate 
and location of VT.
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